BAMCO INC /NY/ - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q4 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$222,525,000
+36.2%
1,292,998
-0.7%
0.50%
+34.8%
Q2 2021$163,422,000
+5.9%
1,302,275
+14.4%
0.37%
-1.8%
Q1 2021$154,365,000
+15.1%
1,138,303
+8.6%
0.38%
+14.8%
Q4 2020$134,087,000
+34.6%
1,048,043
+18.4%
0.33%
+8.5%
Q3 2020$99,643,000
+149.6%
885,475
+111.3%
0.31%
+112.5%
Q2 2020$39,926,000
+45.3%
419,078
+37.1%
0.14%
+6.7%
Q1 2020$27,477,000
+61.6%
305,743
-4.6%
0.14%
+107.7%
Q4 2019$16,998,000
+46.9%
320,600
+9.5%
0.06%
+35.4%
Q3 2019$11,570,000
+39.9%
292,834
+45.4%
0.05%
+45.5%
Q2 2019$8,273,000
+47.2%
201,384
+66.9%
0.03%
+37.5%
Q1 2019$5,620,000
+83.7%
120,677
+71.8%
0.02%
+60.0%
Q4 2018$3,059,000
-22.9%
70,231
+1.3%
0.02%
-6.2%
Q3 2018$3,966,000
+22.2%
69,303
+3.6%
0.02%
+14.3%
Q2 2018$3,245,000
+46.1%
66,878
+17.7%
0.01%
+40.0%
Q1 2018$2,221,000
-2.9%
56,815
+5.4%
0.01%
-9.1%
Q4 2017$2,287,000
+35.6%
53,880
+19.3%
0.01%
+37.5%
Q3 2017$1,686,000
+23.2%
45,180
+0.3%
0.01%
+14.3%
Q2 2017$1,369,00045,0380.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders